Casein kinase 2-interacting protein-1, an inflammatory signaling molecule interferes with TNF reverse signaling in human model cells

Immunology Letters

Volumn 152, Issue 1, 2013, Pages 55-64

  Juhász, Kata ^a,b   Zvara, Ágnes ^b   Lipp, Anna Maria ^a   Nimmervoll, Benedikt ^a   Sonnleitner, Alois ^a   Balogi, Zsolt ^a   Duda, Erno ^b,c  

^a Center for Advanced Bioanalysis GmbH   (Austria)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

CKIP 1; Infliximab; Monocytes; Reverse signaling; Transmembrane TNF

Indexed keywords

BINDING PROTEIN; CASEIN KINASE II; CASEIN KINASE II INTERACTING PROTEIN 1; LIPOPOLYSACCHARIDE; PROTEIN C JUN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL DEATH; CELL DIFFERENTIATION; CELL MEMBRANE; CELL MOTILITY; CONTROLLED STUDY; GENE ACTIVATION; HUMAN; HUMAN CELL; INFLAMMATION; INTRACELLULAR SIGNALING; INTRACELLULAR SPACE; MOLECULAR MECHANICS; MONOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; TRANSACTIVATION;

APOPTOSIS; CARRIER PROTEINS; FEEDBACK, PHYSIOLOGICAL; HEK293 CELLS; HUMANS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MEMBRANE PROTEINS; MONOCYTES; PROMOTER REGIONS, GENETIC; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TRANSGENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877804872     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2013.04.001     Document Type: Article

References (44)

1. Black R.A. Tumor necrosis factor-alpha converting enzyme. Int J Biochem Cell Biol 2002, 34:1-5.
2. van Essen D., Kikutani H., Gray D. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 1995, 378:620-623.
3. Stuber E., Neurath M., Calderhead D., Fell H.P., Strober W. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 1995, 2:507-521.
4. Wiley S.R., Goodwin R.G., Smith C.A. Reverse signaling via CD30 ligand. J Immunol 1996, 157:3635-3639.
5. Suzuki I., Fink P.J. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J Exp Med 1998, 187:123-128.
6. Lens S.M., Drillenburg P., den Drijver B.F., van Schijndel G., Pals S.T., van Lier R.A., et al. Aberrant expression and reverse signalling of CD70 on malignant B cells. Br J Haematol 1999, 106:491-503.
7. Langstein J., Michel J., Schwarz H. CD137 induces proliferation and endomitosis in monocytes. Blood 1999, 94:3161-3168.
8. Chou A.H., Tsai H.F., Lin L.L., Hsieh S.L., Hsu P.I., Hsu P.N. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand. J Immunol 2001, 167:1347-1352.
9. Chen N.J., Huang M.W., Hsieh S.L. Enhanced secretion of IFN-gamma by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine. J Immunol 2001, 166:270-276.
10. Pocsik E., Duda E., Wallach D. Phosphorylation of the 26 kDa TNF precursor in monocytic cells and in transfected HeLa cells. J Inflamm 1995, 45:152-160.
11. Watts A.D., Hunt N.H., Wanigasekara Y., Bloomfield G., Wallach D., Roufogalis B.D., et al. A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling'. EMBO J 1999, 18:2119-2126.
12. Eissner G., Kirchner S., Lindner H., Kolch W., Janosch P., Grell M., et al. Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages. J Immunol 2000, 164:6193-6198.
13. Domonkos A., Udvardy A., Laszlo L., Nagy T., Duda E. Receptor-like properties of the 26 kDa transmembrane form of TNF. Eur Cytokine Netw 2001, 12:411-419.
14. Kirchner S., Boldt S., Kolch W., Haffner S., Kazak S., Janosch P., et al. LPS resistance in monocytic cells caused by reverse signaling through transmembrane TNF (mTNF) is mediated by the MAPK/ERK pathway. J Leukoc Biol 2004, 75:324-331.
15. Mitoma H., Horiuchi T., Hatta N., Tsukamoto H., Harashima S., Kikuchi Y., et al. Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha. Gastroenterology 2005, 128:376-392.
16. Mitoma H., Horiuchi T., Tsukamoto H., Tamimoto Y., Kimoto Y., Uchino A., et al. Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab. Arthritis Rheum 2008, 58:1248-1257.
17. Van den Brande J.M., Braat H., van den Brink G.R., Versteeg H.H., Bauer C.A., Hoedemaeker I., et al. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 2003, 124:1774-1785.
18. Meusch U., Rossol M., Baerwald C., Hauschildt S., Wagner U. Outside-to-inside signaling through transmembrane tumor necrosis factor reverses pathologic interleukin-1beta production and deficient apoptosis of rheumatoid arthritis monocytes. Arthritis Rheum 2009, 60:2612-2621.
19. Waetzig G.H., Rosenstiel P., Arlt A., Till A., Brautigam K., Schafer H., et al. Soluble tumor necrosis factor (TNF) receptor-1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor-beta1. FASEB J 2005, 19:91-93.
20. Vudattu N.K., Holler E., Ewing P., Schulz U., Haffner S., Burger V., et al. Reverse signalling of membrane-integrated tumour necrosis factor differentially regulates alloresponses of CD4+ and CD8+ T cells against human microvascular endothelial cells. Immunology 2005, 115:536-543.
21. Keane J., Gershon S., Wise R.P., Mirabile-Levens E., Kasznica J., Schwieterman W.D., et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001, 345:1098-1104.
22. Bosc D.G., Graham K.C., Saulnier R.B., Zhang C., Prober D., Gietz R.D., et al. Identification and characterization of CKIP-1, a novel pleckstrin homology domain-containing protein that interacts with protein kinase CK2. J Biol Chem 2000, 275:14295-14306.
23. Canton D.A., Olsten M.E., Kim K., Doherty-Kirby A., Lajoie G., Cooper J.A., et al. The pleckstrin homology domain-containing protein CKIP-1 is involved in regulation of cell morphology and the actin cytoskeleton and interaction with actin capping protein. Mol Cell Biol 2005, 25:3519-3534.
24. Zhang L., Xing G., Tie Y., Tang Y., Tian C., Li L., et al. Role for the pleckstrin homology domain-containing protein CKIP-1 in AP-1 regulation and apoptosis. EMBO J 2005, 24:766-778.
25. Paar C., Paster W., Stockinger H., Schutz G.J., Sonnleitner M., Sonnleitner A. High throughput FRET screening of the plasma membrane based on TIRFM. Cytometry A 2008, 73:442-450.
26. Muller J.M., Ziegler-Heitbrock H.W., Baeuerle P.A. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 1993, 187:233-256.
27. Rhoades K.L., Golub S.H., Economou J.S. The regulation of the human tumor necrosis factor alpha promoter region in macrophage, T cell, and B cell lines. J Biol Chem 1992, 267:22102-22107.
28. Baldwin H.M., Ito-Ihara T., Isaacs J.D., Hilkens C.M. Tumour necrosis factor alpha blockade impairs dendritic cell survival and function in rheumatoid arthritis. Ann Rheum Dis 2010, 69:1200-1207.
29. Coury F., Ferraro-Peyret C., Le Cam S., Guerin S., Tebib J., Sibilia J., et al. Peripheral blood lymphocytes from patients with rheumatoid arthritis are differentially sensitive to apoptosis induced by anti-tumour necrosis factor-alpha therapy. Clin Exp Rheumatol 2008, 26:234-239.
30. Shen C., Maerten P., Geboes K., Van Assche G., Rutgeerts P., Ceuppens J.L. Infliximab induces apoptosis of monocytes and T lymphocytes in a human-mouse chimeric model. Clin Immunol 2005, 115:250-259.
31. Zhang L., Tie Y., Tian C., Xing G., Song Y., Zhu Y., et al. CKIP-1 recruits nuclear ATM partially to the plasma membrane through interaction with ATM. Cell Signal 2006, 18:1386-1395.
32. Tokuda E., Fujita N., Oh-hara T., Sato S., Kurata A., Katayama R., et al. Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo. Cancer Res 2007, 67:9666-9676.
33. Zhang L., Tang Y., Tie Y., Tian C., Wang J., Dong Y., et al. domain containing protein CKIP-1 binds to IFP35 and Nmi and is involved in cytokine signaling. Cell Signal 2007, 19:932-944.
34. Lu K., Yin X., Weng T., Xi S., Li L., Xing G., et al. domains linker of HECT-type ubiquitin ligase Smurf1 for activation by CKIP-1. Nat Cell Biol 2008, 10:994-1002.
35. Olsten M.E., Canton D.A., Zhang C., Walton P.A., Litchfield D.W. The Pleckstrin homology domain of CK2 interacting protein-1 is required for interactions and recruitment of protein kinase CK2 to the plasma membrane. J Biol Chem 2004, 279:42114-42127.
36. Safi A., Vandromme M., Caussanel S., Valdacci L., Baas D., Vidal M., et al. Role for the pleckstrin homology domain-containing protein CKIP-1 in phosphatidylinositol 3-kinase-regulated muscle differentiation. Mol Cell Biol 2004, 24:1245-1255.
37. Xi S., Tie Y., Lu K., Zhang M., Yin X., Chen J., et al. domain and C-terminal auto-inhibitory region of CKIP-1 coordinate to determine its nucleus-plasma membrane shuttling. FEBS Lett 2010, 584:1223-1230.
38. Xin L., Wang J., Zhang H., Shi W., Yu M., Li Q., et al. Dual regulation of soluble tumor necrosis factor-alpha induced activation of human monocytic cells via modulating transmembrane TNF-alpha-mediated 'reverse signaling'. Int J Mol Med 2006, 18:885-892.
39. Yu M., Shi W., Zhang J., Niu L., Chen Q., Yan D., et al. Influence of reverse signaling via membrane TNF-alpha on cytotoxicity of NK92 cells. Eur J Cell Biol 2009, 88:181-191.
40. Rossol M., Meusch U., Pierer M., Kaltenhauser S., Hantzschel H., Hauschildt S., et al. Interaction between transmembrane TNF and TNFR1/2 mediates the activation of monocytes by contact with T cells. J Immunol 2007, 179:4239-4248.
41. Sugita S., Yamada Y., Kaneko S., Horie S., Mochizuki M. Induction of regulatory T cells by infliximab in Behcet's disease. Invest Ophthalmol Vis Sci 2011, 52:476-484.
42. Harashima S., Horiuchi T., Hatta N., Morita C., Higuchi M., Sawabe T., et al. Outside-to-inside signal through the membrane TNF-alpha induces E-selectin (CD62E) expression on activated human CD4+ T cells. J Immunol 2001, 166:130-136.
43. Abd-Elrahman I., Hershko K., Neuman T., Nachmias B., Perlman R., Ben-Yehuda D. The inhibitor of apoptosis protein Livin (ML-IAP) plays a dual role in tumorigenicity. Cancer Res 2009, 69:5475-5480.
44. Oswald F., Tauber B., Dobner T., Bourteele S., Kostezka U., Adler G., et al. p300 acts as a transcriptional coactivator for mammalian Notch-1. Mol Cell Biol 2001, 21:7761-7774.